Physician profile
Sandeepkumar Gupta
NPI 1528485729
$3,805.93
in general payments reported to CMS, 2019-2025
19 companies · $830 in 2025
The $830 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.17 · 2021: $46.80 · 2022: $218 · 2023: $2,159 · 2024: $535 · 2025: $830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,840 · Food and Beverage: $1,654 · Travel and Lodging: $30.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,840.00 |
| Food and Beverage | $1,653.77 |
| Travel and Lodging | $30.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,902.55 | 2023 | Cimzia |
| Amgen INC. | $346.58 | 2019-2025 | Krystexxa, Otezla, Uplizna |
| Pfizer INC. | $279.18 | 2023-2024 | |
| Abbvie INC. | $249.33 | 2021-2025 | |
| Janssen Biotech, INC. | $150.96 | 2024-2025 | Tremfya, Simponi Aria |
| Astrazeneca Pharmaceuticals LP | $150.69 | 2024 | Saphnelo |
| Genzyme Corporation | $138.51 | 2025 | |
| Boston Scientific Corporation | $118.06 | 2022 | |
| Cardinal Health 110 LLC | $100.00 | 2022 | |
| Glaxosmithkline, LLC. | $82.75 | 2024-2025 | Benlysta |
| Horizon Therapeutics Plc | $54.16 | 2023 | Krystexxa |
| Alexion Pharmaceuticals, INC. | $47.49 | 2025 | Strensiq |
| E.R. Squibb & Sons, L.L.C. | $37.60 | 2025 | Orencia |
| Genentech USA, INC. | $29.52 | 2023 | Actemra |
| Novartis Pharmaceuticals Corporation | $28.59 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.57 | 2025 | Ofev |
| Sonex Health, INC. | $23.69 | 2025 | Sx-One Microknife |
| Medtronic, INC. | $23.12 | 2023 | Intellis Adaptivestim |
| Actelion Pharmaceuticals US, INC. | $17.58 | 2024 | Opsumit, Uptravi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeepkumar Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.